ALLMedicine™ Primary Pulmonary Hypertension Center

Dec 3rd, 2020 - An 8-day-old neonate was presented with severe respiratory distress and diagnosed as primary pulmonary hypertension of the newborn on functional echocardiogram. Evaluation showed bounding pulse, enlarged umbilical cord, and bruit over the periumbi...

Aug 11th, 2020 - To investigate the microvascular and neural changes in primary pulmonary hypertension (PPH) patients compared with healthy controls. Forty-four eyes of 22 PPH patients were included in this observational clinical cohort study, and 44 eyes of 22 he...

Jun 1st, 2020 - Lung transplant remains the only viable treatment for certain patients with end-stage lung diseases. Such patients can become either single or double lung recipients. The 2 procedures are associated with specific risks and benefits. The aim of the...

Apr 7th, 2020 - Primary pulmonary hypertension can lead to hypertrophy of the right ventricle and ultimately to its insufficiency. Lung transplantation remains the only viable treatment for patients with certain forms of this disease. Usage of extracorporeal memb...

Mar 30th, 2020 - Following introduction of the lung allocation score (LAS) in 2011, Eurotransplant member centers can apply for an exceptional LAS (eLAS) if the calculated LAS insufficiently reflects the perceived transplant benefit for a patient, specifically in ...

Mar 17th, 2020 - Introduction: Primary pulmonary hypertension, now known as idiopathic pulmonary arterial hypertension (IPAH), a subgroup of pulmonary arterial hypertension (PAH), is a rare disorder characterized by severe morbidity and high mortality rates. There...

Aug 9th, 2018 - We propose a randomized trial to determine the safety and effectiveness of aerobic exercise for patients who have primary pulmonary hypertension (PH) or PH secondary to interstitial lung disease (ILD). This project will be the first in a series of...

Mar 23rd, 2018 - Pulmonary hypertension (PH) refers to abnormalities in the pulmonary vasculature associated with a diverse group of disorders. The World Health Organization (WHO) classifies pulmonary hypertension into five groups, with Group I comprising pulmonar...

Dec 28th, 2017 - Primary whose mechanisms are incompletely known, is another vascular disease entity recently described in chronic kidney disease particularly in patients undergoing haemodialysis. It corresponds to 5th subtype of World Symposium on Pulmonary Hyper...

Sep 26th, 2017 - Respiratory failure occurs in near term and term infants as a complication of perinatal aspiration syndromes, pneumonia, sepsis, respiratory distress syndrome and primary pulmonary hypertension. Recently a collaborative trial of the NICHD Neonatal...

May 19th, 2014 - Endothelin inhibitors Endothelin inhibitors also may play a role in vascular protection. Endothelin is secreted in scleroderma and is a potent vasoconstrictor.

Apr 20th, 2012 - Answer Right ventricular hypertrophy Discussion In this tracing, QRS axis tends to the right axis deviation (RAD), which should make one think of right ventricular hypertrophy (RVH) first. After the RAD, all other diagnostic features of RVH are fo...

Nov 28th, 2011 - November 28, 2011 (Chicago, Illinois) — Approximately half of the neonates who receive extracorporeal membrane oxygenation (ECMO) have cerebral atrophy. Magnetic resonance imaging (MRI) has shown that the N-acetylaspartate/creatine (NAA/Cr) ratio ...

Apr 6th, 2011 - ORLANDO – Endobronchial dysplasia appears useful as a biomarker for measuring the success of lung cancer chemoprevention, investigators reported at the annual meeting of the American Association for Cancer Research. Bronchoscopies, along with biop.

Dec 10th, 2010 - December 10, 2010 (New York, New York) — Pfizer is to voluntarily withdraw sitaxentan (Thelin), a drug for pulmonary arterial hypertension (PAH), following two cases of fatal liver toxicity [1]. The drug has been marketed in 16 countries in the Eu...